COR Therapeutics, Inc
Article Abstract:
COR Therapeutics Inc is developing a new product called Integrelin. The new drug is formulated for the prevention of blood clotting for patients with cardiovascular problems. The principal drug mechanism of the new product involves inhibition of platelets aggregation. Evidently, Integrelin has a drug efficacy greater than that of aspirin. The product already shows lucrative prospects in the market. West Highland Capital Inc bought 320,000 shares worth five million dollars at 9 3/4-16 1/2. Currently, the stock is pegged at 11 5/8. The company does not pay dividends on the 11.8 million shares.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
McKesson Corp
Article Abstract:
McKesson Corp's stockholders had some relief from the company's poor performance in the market with the renewal of its Wal-Mart Stores Inc contract. The contract, which makes McKesson the major vendor of prescription drugs and some over-the-counter health care products to Wal-Mart Stores, can give the San Francisco distributor of pharmaceutical products $4 billion in sales. The projected worth of the contract is 10 times the $415 million contract McKesson had with Wal-Mart 2 1/2 years ago.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
Noven Pharmaceuticals Inc
Article Abstract:
Rhone-Poulenc Rorer Inc has been a granted a five-year warrant to purchase one million shares of Noven Pharmaceuticals Inc at $8 each. Rhone-Poulenc's warrant came after received licensing to manufacture and market three transdermal hormone replacement delivery systems for women suffering postmenopausal disorders being developed by Noven. The agreement with Rhone-Poulenc followed Noven's earlier licensing agreement with CIBA-GEIGY Corp.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
User Contributions:
Comment about this article or add new information about this topic: